Instil Bio(NASDAQ) TIL

Market Cap$47.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-99%
5 Year-98%
1 Year-62%
1 Month-8%
$7.00
-3.05%
-0.22Today
After hours$6.97-$0.03 (-0.43%)
Instil Bio last closing stock price
MetricPriceDate
Last closeUSD 6.952026-10-05
Instil Bio stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.28%USD 7.042026-09-28
1 month-8.31%USD 7.582026-09-04
3 month-10.32%USD 7.752026-07-07
Year to date-36.82%USD 11.002025-12-31
1 year-61.6%USD 18.102025-10-03
3 year-8.55%USD 7.602023-10-06
5 year-98.02%USD 351.402021-10-06
Since inception-98.69%USD 528.802021-03-19

Instil Bio Financials at a Glance

Market Cap

$47.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$30.28

EPS (TTM)

-$4.47

P/E Ratio

-1.55

Dividend

$0.00

Beta (Volatility)

1.61 (High)

Price

$7.00

Volume

12,944.699

Open

$7.22

Previous Close

$6.95

Daily Range

$6.95 - $7.35

52-Week Range

$5.67 - $21.98

Estimated Earnings Date

N/A

TIL News

Foolcom-Featured.png

Instil Bio Posts Wider Loss in Q2

Motley Fool Markets TeamAug 13, 2025
investing-screen-analysis-investor-growth-stocks-getty

Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher?

Cory RenauerSep 14, 2024
GettyImages-667015964

At a Recent Cancer Research Conference, Instil Bio Stole the Show

Patrick BafumaApr 29, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Instil Bio

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.

Industry

Biotechnology

Sector

Health Care

Employees

17

CEO

Bronson Crouch

Website

www.instilbio.com

TIL Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-25.33%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-64.52%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$47.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.78M

Volume

12.94K

Avg. Volume

11.80K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Instil Bio Performance Analysis

Instil Bio annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Instil Bio annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -34.4641.8%
20232023-12-31USD -24.00-30.4%
20242024-12-31USD -11.39-52.5%
20252025-12-31USD -10.70-6.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.25

+20.8%

Gross Margin

N/A

N/A

Market Cap

$47.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.07

N/A

Employees

17

N/A

Net Income

-$4.30

+0.2%

EBITDA

-$5.15

+0.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$93.22

+0.5%

Total Debt

$87.42

+1.0%

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$87.03

+1.0%

Short Term Debt

$0.39

+0.9%

Return on Assets

-14.13%

+0.4%

Return on Invested Capital

-38.84%

+1.1%

Free Cash Flow

-$4.64

+0.3%

Operating Cash Flow

-$4.64

+0.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,777.74+0.01%
^DJIDJI
$51,304.21+0.00%
^IXICNASDAQ
$27,461.27+0.01%
BTCBitcoin
$85,510.00+0.00%

Questions About TIL

What is the current price of Instil Bio?

Instil Bio is trading at $6.95 per share.

What is the 52-week range for Instil Bio?

Over the past 52 weeks, Instil Bio has traded between $5.67 and $21.98.

How much debt does Instil Bio have?

As of the most recent reporting period, Instil Bio reported total debt of $87.42M.

How much cash does Instil Bio have on hand?

Instil Bio reported $5.80M in cash and cash equivalents in its most recent financial results.

What is Instil Bio’s dividend yield?

Instil Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services